文献速递脊柱脊髓外科神经肿瘤

环形圆周脊柱射波刀立体定向体部放疗治疗转移性脊柱疾病的有效性与安全性

Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease.
PubMed 文献 · Neurosurgery · 2025-04-17

本研究回顾性分析2014—2023年接受环形圆周射波刀立体定向体部放疗的43例患者共48个脊柱转移病灶,中位随访8个月,6个月、1年、3年、5年局部肿瘤控制率分别为91.1%、87.1%、82.8%、62.1%,中位总生存期17个月,仅1例出现临床脊髓病,未见影像学脊髓病或其他放射性并发症。

要点

  • 43例患者48个病灶,中位年龄65岁(范围20-78),中位随访8个月
  • 局部肿瘤控制率6个月91.1%、1年87.1%、3年82.8%、5年62.1%,中位总生存期17个月
  • 21个病灶超出剂量约束,仅1例出现临床脊髓病,且与局部肿瘤复发相关

核心结论

  • 环形圆周射波刀立体定向体部放疗是治疗脊柱转移的安全有效方法,局部肿瘤控制率高,放射性并发症(包括脊髓病)极少。

研究设计与样本

  • 回顾性分析2014—2023年接受环形圆周立体定向体部放疗的患者资料,共43例患者48个病灶,中位年龄65岁(范围20-78)。
  • 分析参数包括患者人口学特征、硬膜外脊髓压迫Bilsky分级、既往治疗、临床症状及治疗参数,重点为立体定向体部放疗剂量学数据、脊髓与马尾的受照剂量、剂量体积约束依从性及治疗后结局(脊髓病与局部肿瘤控制)。

主要发现

  • 中位临床靶体积为63.77 cm³,中位边缘剂量为24 Gy,中位随访8个月。
  • 局部肿瘤控制率6个月为91.1%、1年为87.1%、3年为82.8%、5年为62.1%,中位总生存期为17个月。
  • 21个病灶超出剂量约束,其中仅1例患者出现临床脊髓病,且与局部肿瘤复发相关;未观察到影像学脊髓病或其他放射性并发症。
  • 1例患者因严重硬膜外脊髓压迫(Bilsky 3级)需行分离手术。

临床怎么用

  • 作者结论认为环形圆周射波刀立体定向体部放疗是脊柱转移的安全有效治疗,可获得高局部肿瘤控制且放射性并发症(包括脊髓病)极少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Spinal metastases (SM) with epidural spinal cord compression (ESCC) present a significant challenge because of the high risk of radiation-induced injury to critical structures such as the spinal cord and nerve roots. Traditional treatment approaches often avoid circumferential stereotactic body radiotherapy (SBRT) to reduce these risks. The efficacy and safety of donut-shaped circumferential SBRT, designed to target the spinal column while sparing the spinal cord, remains underexplored. The aim of this study was to evaluate the safety and efficacy of donut-shaped circumferential CyberKnife SBRT for SM, particularly in preventing radiation-induced myelopathy and achieving local tumor control (LTC). METHODS: We retrospectively analyzed data from patients treated with donut-shaped circumferential SBRT between 2014 and 2023. Key parameters examined included patient demographics, ESCC grade (Bilsky), prior treatments, clinical symptoms, and treatment parameters. We focused on SBRT dosimetric data, radiation exposure to the spinal cord and cauda equina, adherence to dose-volume constraints, and post-SBRT outcomes, including myelopathy and LTC. RESULTS: Forty-eight lesions in 43 patients (median age: 65; range: 20-78) were reviewed. One patient required separation surgery for severe ESCC (Bilsky grade 3). The median clinical target volume was 63.77 cm 3 , and the median margin dose was 24 Gy. Over a median follow-up of 8 months, LTC was 91.1% at 6 months, 87.1% at 1 year, 82.8% at 3 years, and 62.1% at 5 years. The median overall survival was 17 months. Of the 21 lesions exceeding dose constraints, only one patient exhibited clinical myelopathy, which correlated with local tumor recurrence. No radiographic myelopathy or other radiation-induced complications were observed. CONCLUSION: Donut-shaped circumferential CyberKnife SBRT is a safe and effective treatment of SM, achieving high LTC with minimal radiation-induced complications, including myelopathy.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Park DJ, Lee I, Annagiri S, et al. Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease. Neurosurgery. 2025. PMID: 40243341. doi:10.1227/neu.0000000000003446

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。